Literature DB >> 15538268

Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer.

Benjamin A Spencer1, Constance H Fung, Mingming Wang, Lisa V Rubenstein, Mark S Litwin.   

Abstract

PURPOSE: We investigated geographic variation in the treatment of early stage prostate cancer in a national sample of veterans after widespread adoption of the prostate specific antigen test.
MATERIALS AND METHODS: Our sample consisted of 16,352 cases from the Veterans Affairs Central Cancer Registry that were diagnosed between January 1997 and December 1999 with stage I or II prostate cancer. We used a 2-stage nested logit model to compare surgery, radiation therapy and noncurative treatment among 4 geographic regions of the United States.
RESULTS: Multivariate analysis showed that patients in the West (referent group) had a higher OR of undergoing surgery than radiation compared with the Northeast, South or Midwest (OR 0.77, 95% CI 0.67 to 0.87, OR 0.86, 95% CI 0.76 to 0.98 and OR 0.75, 95% CI 0.64 to 0.87, respectively. Black men, men with lower grade and higher stage tumors, and unmarried men were less likely to undergo curative treatment and less likely to undergo surgery than radiation.
CONCLUSIONS: Geographic variation persists in patterns of care in men with early stage prostate cancer. However, this variation is limited to the choice between surgery and radiation rather than to the choice between curative and noncurative treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15538268     DOI: 10.1097/01.ju.0000144064.54670.7b

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.

Authors:  Shi-Yi Wang; Rong Wang; James B Yu; Xiaomei Ma; Xiao Xu; Simon P Kim; Pamela R Soulos; Avantika Saraf; Cary P Gross
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

2.  Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).

Authors:  Maria J Schymura; Amy R Kahn; Robert R German; Mei-Chin Hsieh; Rosemary D Cress; Jack L Finch; John P Fulton; Tiefu Shen; Erik Stuckart
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

3.  Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Askal Ali; Georges Adunlin; Clement K Gwede; Youjie Huang
Journal:  Am J Mens Health       Date:  2013-12-01

4.  Factors associated with time-to-treatment of prostate cancer in Florida.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Georges Adunlin; Askal Ali; Youjie Huang; Clement K Gwede
Journal:  J Health Care Poor Underserved       Date:  2013-11

5.  Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive?

Authors:  Andrew S Camarata; Dana C Nickleach; Ashesh B Jani; Peter J Rossi
Journal:  Health Serv Insights       Date:  2015-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.